Trump reclassifies medical marijuana, easing regulations and taxes

President Donald Trump's acting attorney general, Todd Blanche, signed an order this week reclassifying state-licensed medical marijuana from Schedule I to Schedule III. This significant policy shift allows for less stringent regulation and provides tax breaks for licensed medical marijuana operators. Blanche stated, "This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information."

The order does not legalize marijuana under federal law but legitimizes medical marijuana programs across the 40 states that have adopted them. It sets up an expedited registration system for state-licensed producers and distributors with the U.S. Drug Enforcement Administration. Furthermore, it clarifies that cannabis researchers will not face penalties for using state-licensed marijuana in their studies.

This reclassification represents a major shift in U.S. drug policy, which has historically maintained a prohibition on marijuana since the Marihuana Tax Act of 1937. The American Trade Association for Cannabis and Hemp's president, Michael Bronstein, called it "the most significant federal advancement in cannabis policy in over 50 years."

However, the decision has drawn criticism from opponents like Kevin Sabet, who labeled it as "a tax break to Big Weed" and expressed concerns about the message it sends regarding marijuana's potential harms. The order sidesteps the review process initiated by the Biden administration, which had sought to reclassify marijuana based on public feedback.

As the Trump administration moves forward with this policy, it may create divisions within the Republican Party, where many members oppose loosening marijuana restrictions. The implications for states with both medical and recreational marijuana markets remain uncertain, particularly in states like Washington, where licensed shops serve both patient demographics.

What to watch: The upcoming hearing set for late June regarding broader marijuana reclassification.